CN1151746A - 新的红霉素衍生物、其制备方法及其作为药物的应用 - Google Patents
新的红霉素衍生物、其制备方法及其作为药物的应用 Download PDFInfo
- Publication number
- CN1151746A CN1151746A CN95193911A CN95193911A CN1151746A CN 1151746 A CN1151746 A CN 1151746A CN 95193911 A CN95193911 A CN 95193911A CN 95193911 A CN95193911 A CN 95193911A CN 1151746 A CN1151746 A CN 1151746A
- Authority
- CN
- China
- Prior art keywords
- methyl
- butylamine
- dideoxy
- oxygen
- imidazoles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Description
Claims (16)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR94/05368 | 1994-05-03 | ||
FR9405368A FR2719587B1 (fr) | 1994-05-03 | 1994-05-03 | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98123072A Division CN1088709C (zh) | 1994-05-03 | 1998-12-07 | 胺类化合物及其酸加成盐 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1151746A true CN1151746A (zh) | 1997-06-11 |
CN1052984C CN1052984C (zh) | 2000-05-31 |
Family
ID=9462785
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95193911A Expired - Lifetime CN1052984C (zh) | 1994-05-03 | 1995-05-02 | 新的红霉素衍生物、其制备方法及其作为药物的应用 |
CN98123072A Expired - Lifetime CN1088709C (zh) | 1994-05-03 | 1998-12-07 | 胺类化合物及其酸加成盐 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98123072A Expired - Lifetime CN1088709C (zh) | 1994-05-03 | 1998-12-07 | 胺类化合物及其酸加成盐 |
Country Status (43)
Country | Link |
---|---|
US (2) | US5635485A (zh) |
EP (1) | EP0680967B1 (zh) |
JP (4) | JP2992540B2 (zh) |
KR (1) | KR100312267B1 (zh) |
CN (2) | CN1052984C (zh) |
AP (1) | AP558A (zh) |
AT (1) | ATE172203T1 (zh) |
AU (1) | AU684027B2 (zh) |
BG (1) | BG63087B1 (zh) |
BR (1) | BR9507700A (zh) |
CA (1) | CA2189271C (zh) |
CZ (1) | CZ293455B6 (zh) |
DE (2) | DE10299001I2 (zh) |
DK (1) | DK0680967T3 (zh) |
DZ (1) | DZ1878A1 (zh) |
EE (1) | EE03263B1 (zh) |
ES (1) | ES2122472T3 (zh) |
FI (1) | FI111263B (zh) |
FR (1) | FR2719587B1 (zh) |
GE (1) | GEP19991538B (zh) |
HK (1) | HK1010732A1 (zh) |
HU (2) | HU227493B1 (zh) |
IL (1) | IL113245A (zh) |
LU (1) | LU90872I2 (zh) |
LV (1) | LV11739B (zh) |
MA (1) | MA23534A1 (zh) |
MD (1) | MD1233C2 (zh) |
NL (1) | NL300077I1 (zh) |
NO (2) | NO308853B1 (zh) |
NZ (1) | NZ285416A (zh) |
OA (1) | OA10319A (zh) |
PL (1) | PL182034B1 (zh) |
RO (1) | RO113350B1 (zh) |
RU (1) | RU2144036C1 (zh) |
SI (1) | SI0680967T1 (zh) |
SK (1) | SK281707B6 (zh) |
TJ (1) | TJ313B (zh) |
TN (1) | TNSN95049A1 (zh) |
TW (1) | TW341573B (zh) |
UA (1) | UA51618C2 (zh) |
WO (1) | WO1995029929A1 (zh) |
YU (1) | YU49235B (zh) |
ZA (1) | ZA953501B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105524132A (zh) * | 2014-09-30 | 2016-04-27 | 中国医学科学院药物研究所 | 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用 |
CN107129514A (zh) * | 2016-03-02 | 2017-09-05 | 中国医学科学院药物研究所 | 红霉素a酮内酯类抗生素衍生物、其制备方法及应用 |
US10820706B2 (en) | 2007-09-20 | 2020-11-03 | Herman Miller, Inc. | Load support structure |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69633289T2 (de) * | 1995-06-27 | 2006-01-12 | Takeda Pharmaceutical Co. Ltd. | 4-acylamino(halogen)alkyl-chinolin derivate, deren herstellung und deren verwendung als melatonin-agonisten |
FR2742757B1 (fr) | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
UA51730C2 (uk) * | 1996-09-04 | 2002-12-16 | Ебботт Лабораторіз | 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців |
DE69733369T2 (de) * | 1996-09-04 | 2006-01-26 | Abbott Laboratories, Abbott Park | 6-o-Substituierte Ketoliden mit antibakteriellen Wirking |
FR2757168B1 (fr) * | 1996-12-12 | 1999-06-11 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2760017B1 (fr) * | 1997-02-27 | 1999-04-30 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments |
US5780605A (en) * | 1997-09-08 | 1998-07-14 | Abbott Laboratories | 6,9-bridged erythromycin derivatives |
FR2771008B1 (fr) * | 1997-11-17 | 2000-04-28 | Hoechst Marion Roussel Inc | Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose |
JP4573925B2 (ja) * | 1998-07-09 | 2010-11-04 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用 |
FR2781484B1 (fr) * | 1998-07-21 | 2001-08-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
DE69926005T2 (de) | 1998-09-22 | 2006-05-18 | Pfizer Products Inc., Groton | Carbamat- und carbazatketolidantibiotika |
FR2785612A1 (fr) * | 1998-11-10 | 2000-05-12 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2786188B1 (fr) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments |
TW526202B (en) | 1998-11-27 | 2003-04-01 | Shionogi & Amp Co | Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity |
ES2273964T3 (es) | 1998-12-10 | 2007-05-16 | Pfizer Products Inc. | Antibioticos de carbamato y carbazato cetolida. |
AU1675400A (en) * | 1999-01-27 | 2000-08-18 | Pfizer Products Inc. | Ketolide antibiotics |
FR2789392B1 (fr) | 1999-02-04 | 2001-10-05 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
US6054435A (en) * | 1999-03-19 | 2000-04-25 | Abbott Laboratories | 6-O-substituted macrolides having antibacterial activity |
US6590083B1 (en) | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
IL145976A0 (en) * | 1999-04-16 | 2002-07-25 | Ortho Mcneil Pharm Inc | Ketolide antibacterials |
US6514944B2 (en) | 1999-04-16 | 2003-02-04 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
US6939861B2 (en) * | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
BR0010680A (pt) | 1999-04-16 | 2002-02-19 | Kosan Biosciences Inc | Agentes antiinfecciosos de macrolìdeo |
US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
JP2003500414A (ja) * | 1999-05-24 | 2003-01-07 | ファイザー・プロダクツ・インク | 13−メチルエリスロマイシン誘導体 |
FR2797875B1 (fr) * | 1999-08-26 | 2001-10-19 | Hoechst Marion Roussel Inc | Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques |
US6946446B2 (en) | 2000-02-24 | 2005-09-20 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
CA2419296C (en) | 2000-08-22 | 2008-12-09 | Basilea Pharmaceutica Ag | New macrolides with antibacterial activity |
FR2821747B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Suspension de telithromycine a gout masque |
WO2003004509A2 (en) * | 2001-07-03 | 2003-01-16 | Chiron Corporation | C12 modified erythromycin macrolides and ketolides having antibacterial activity |
US8063021B2 (en) * | 2002-01-17 | 2011-11-22 | Kosan Biosciences Incorporated | Ketolide anti-infective compounds |
US6995143B2 (en) | 2002-02-28 | 2006-02-07 | Basilea Pharmaceutica Ag | Macrolides with antibacterial activity |
AU2003264917A1 (en) | 2002-07-08 | 2004-01-23 | Pliva - Istrazivacki Institut D.O.O. | Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
US7091187B2 (en) | 2002-07-08 | 2006-08-15 | Pliva-Istrazivacki Institut D.O.O. | Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
WO2004009059A1 (en) * | 2002-07-19 | 2004-01-29 | Aventis Pharma S.A. | Taste masked oral composition of telithromycin |
US20040013737A1 (en) * | 2002-07-19 | 2004-01-22 | Philippe Becourt | Taste masked oral composition of telithromycin |
US7091196B2 (en) | 2002-09-26 | 2006-08-15 | Rib-X Pharmaceuticals, Inc. | Bifunctional heterocyclic compounds and methods of making and using same |
US6916934B2 (en) * | 2003-02-11 | 2005-07-12 | Aventis Pharma Deutschland Gmbh | Process for preparing pyridine-substituted amino ketal derivatives |
EP2664331B1 (en) * | 2003-03-10 | 2015-09-16 | Merck Sharp & Dohme Corp. | Novel Antibacterial Agents |
US7163924B2 (en) * | 2003-04-25 | 2007-01-16 | Chiron Corporation | Ketolide derivatives |
EP1670808A1 (en) * | 2003-09-12 | 2006-06-21 | Chiron Corporation | Antimicrobial derivatives |
GB0402578D0 (en) * | 2004-02-05 | 2004-03-10 | Cambridge Theranostics Ltd | Methods of treatment of atherosclerosis |
EP1723159B1 (en) | 2004-02-27 | 2019-06-12 | Melinta Therapeutics, Inc. | Macrocyclic compounds and methods of making and using the same |
CA2559281A1 (en) * | 2004-04-28 | 2005-11-10 | Alembic Limited | Process for the preparation of telithromycin |
US20080287376A1 (en) * | 2004-07-28 | 2008-11-20 | Mohammad Salman | Ketolide Derivatives as Antibacterial Agents |
WO2006046112A2 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
AU2005317735B2 (en) * | 2004-12-21 | 2009-06-04 | Pfizer Products Inc. | Macrolides |
CN101116154A (zh) * | 2005-02-08 | 2008-01-30 | 株式会社村田制作所 | 表面安装型负特性热敏电阻 |
FR2882522B1 (fr) | 2005-02-25 | 2007-04-13 | Aventis Pharma Sa | Composition pharmaceutique solide comprenant de la telithromycine |
WO2006129257A2 (en) * | 2005-05-30 | 2006-12-07 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
WO2007039914A2 (en) * | 2005-10-06 | 2007-04-12 | Alembic Limited | Novel polymorphs of telithromycin |
WO2007049296A2 (en) * | 2005-10-28 | 2007-05-03 | Alembic Limited | Amorphous form of telithromycin |
WO2007059307A2 (en) * | 2005-11-15 | 2007-05-24 | Teva Pharmaceutical Industries Ltd. | Crystalline and amorphous forms of telithromycin |
US20090005325A1 (en) * | 2005-11-23 | 2009-01-01 | Biswajit Bas | Ketolide Derivatives as Antibacterial Agents |
US20090130225A1 (en) * | 2005-11-23 | 2009-05-21 | Anjan Chakrabarti | Macrolides derivatives as antibacterial agents |
US20090075916A1 (en) * | 2005-11-23 | 2009-03-19 | Upadhyay Dilip J | Use of Macrolide Derivatives for Treating Acne |
US7595300B2 (en) | 2005-12-13 | 2009-09-29 | Kosan Biosciences Incorporated | 7-quinolyl ketolide antibacterial agents |
GB0600238D0 (en) * | 2006-01-06 | 2006-02-15 | Sandoz Ag | Organic compounds |
US8097708B2 (en) * | 2006-02-07 | 2012-01-17 | Taisho Pharmaceutical Co., Ltd. | 10a-Azalide compound |
CA2661538A1 (en) | 2006-08-24 | 2008-02-28 | Wockhardt Research Centre | Novel macrolides and ketolides having antimicrobial activity |
WO2008023383A1 (en) * | 2006-08-25 | 2008-02-28 | Alembic Limited | Novel process for the preparation of telithromycin |
ES2306590B1 (es) * | 2006-12-15 | 2009-08-07 | Ercros Industrial,S .A. | Formas cristalinas i y ii de telitromicina. |
EP2177526A4 (en) * | 2007-08-06 | 2012-08-22 | Taisho Pharmaceutical Co Ltd | 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12 |
US20090075917A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched telithromycin |
EP2220104A1 (en) * | 2007-10-25 | 2010-08-25 | Sandoz AG | Process for the production of telithromycin |
CN101917850B (zh) | 2007-10-25 | 2016-01-13 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
JPWO2009139181A1 (ja) | 2008-05-15 | 2011-09-15 | 大正製薬株式会社 | 4員環構造を有する10a−アザライド化合物 |
US9072759B2 (en) | 2008-10-24 | 2015-07-07 | Cempra Pharmaceuticals, Inc. | Biodefenses using triazole-containing macrolides |
KR101566053B1 (ko) | 2009-05-27 | 2015-11-04 | 욱크하르트 리미티드 | 항균 활성을 갖는 케톨라이드 |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
EP2475253B1 (en) | 2009-09-10 | 2016-10-26 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and mac diseases |
CN103080122A (zh) | 2010-03-22 | 2013-05-01 | 森普拉制药公司 | 大环内脂的结晶形式及其用途 |
KR101945324B1 (ko) | 2010-05-20 | 2019-02-07 | 셈프라 파마슈티컬스, 인크. | 매크로라이드들 및 케톨라이드들과 이의 중간체들을 제조하는 공정들 |
WO2012034058A1 (en) * | 2010-09-10 | 2012-03-15 | Cempra Pharmaceuticals, Inc. | Hydrogen bond forming fluoro ketolides for treating diseases |
EP3216798A3 (en) | 2010-12-09 | 2017-10-25 | Wockhardt Limited | Ketolide compounds |
AR085286A1 (es) | 2011-02-21 | 2013-09-18 | Taisho Pharmaceutical Co Ltd | Derivado de macrolido sustituido en la posicion c-4 |
WO2012117357A2 (en) | 2011-03-01 | 2012-09-07 | Wockhardt Limited | Process for preparation of ketolide intermediates |
US8993739B2 (en) | 2011-03-22 | 2015-03-31 | Wockhardt Ltd. | Process for preparation of ketolide compounds |
AU2013239696C1 (en) | 2012-03-27 | 2018-11-29 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
RU2015138796A (ru) | 2013-03-14 | 2017-04-19 | Семпра Фармасьютикалс, Инк. | Способы и составы для лечения респираторных заболеваний |
BR112015023670A2 (pt) | 2013-03-15 | 2017-07-18 | Cempra Pharmaceuticals Inc | processo para preparar um composto |
DE102015201783A1 (de) | 2015-02-02 | 2016-08-04 | Friedrich Baur | Verfahren zur Herstellung eines Füllstoffs aus Textilfasern sowie Textil mit einem solchen Füllstoff |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2833140A1 (de) * | 1978-07-28 | 1980-02-07 | Boehringer Sohn Ingelheim | Neue n-substituierte heterocyclen |
IE810250L (en) * | 1980-02-11 | 1981-08-11 | Berlex Lab | N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines. |
US4434174A (en) * | 1980-02-11 | 1984-02-28 | Berlex Laboratories, Inc. | Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines |
US4568687A (en) * | 1983-02-28 | 1986-02-04 | American Cyanamid Company | N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions |
ZA84949B (en) * | 1983-04-06 | 1984-09-26 | American Cyanamid Co | Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides |
US4489089A (en) * | 1983-04-06 | 1984-12-18 | American Cyanamid Company | Substituted N-[ω-(1H-imidazol-1-yl)alkyl]-amides |
AU573828B2 (en) * | 1984-05-17 | 1988-06-23 | E.R. Squibb & Sons, Inc. | Tetrahydronaphthalenols |
GB8425104D0 (en) * | 1984-10-04 | 1984-11-07 | Ici America Inc | Amide derivatives |
DE3540376A1 (de) * | 1985-11-14 | 1987-05-21 | Bayer Ag | Verfahren zur inhibierung der wasserstoffinduzierten korrosion von metallischen werkstoffen |
ES2054684T3 (es) * | 1986-10-29 | 1994-08-16 | Pfizer | Procedimientos para la preparacion de 2-(1-pentil-3-guanidino)-4-(2-metil-4-imidazolil) tiazol y el dihidrocloruro trihidratado cristalino del mismo. |
DE3930669A1 (de) * | 1989-09-14 | 1991-03-28 | Basf Ag | Verfahren zur herstellung von uretdiongruppen aufweisenden polyisocyanaten |
JP2899028B2 (ja) * | 1989-12-01 | 1999-06-02 | 協和醗酵工業株式会社 | ジベンゾオキセピン誘導体 |
IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
DE69127457T2 (de) * | 1990-11-28 | 1998-01-22 | Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo | 6-0-methylerythromycin a-derivat |
FR2692579B1 (fr) * | 1992-06-19 | 1995-06-02 | Roussel Uclaf | Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments. |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
TW444018B (en) * | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
HRP930014A2 (en) * | 1993-01-08 | 1994-08-31 | Pliva Pharm & Chem Works | 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates |
-
1994
- 1994-05-03 FR FR9405368A patent/FR2719587B1/fr not_active Expired - Lifetime
-
1995
- 1995-02-05 UA UA96104110A patent/UA51618C2/uk unknown
- 1995-04-04 IL IL11324595A patent/IL113245A/xx not_active IP Right Cessation
- 1995-04-21 US US08/426,067 patent/US5635485A/en not_active Expired - Lifetime
- 1995-04-27 MA MA23866A patent/MA23534A1/fr unknown
- 1995-04-28 YU YU27095A patent/YU49235B/sh unknown
- 1995-05-01 JP JP7128791A patent/JP2992540B2/ja not_active Expired - Lifetime
- 1995-05-02 CA CA002189271A patent/CA2189271C/fr not_active Expired - Lifetime
- 1995-05-02 AU AU24499/95A patent/AU684027B2/en not_active Expired
- 1995-05-02 DE DE2002199001 patent/DE10299001I2/de active Active
- 1995-05-02 ZA ZA953501A patent/ZA953501B/xx unknown
- 1995-05-02 NZ NZ285416A patent/NZ285416A/en not_active IP Right Cessation
- 1995-05-02 AT AT95400987T patent/ATE172203T1/de active
- 1995-05-02 KR KR1019960706191A patent/KR100312267B1/ko not_active IP Right Cessation
- 1995-05-02 DK DK95400987T patent/DK0680967T3/da active
- 1995-05-02 EP EP95400987A patent/EP0680967B1/fr not_active Expired - Lifetime
- 1995-05-02 SI SI9530184T patent/SI0680967T1/xx unknown
- 1995-05-02 PL PL95317071A patent/PL182034B1/pl unknown
- 1995-05-02 HU HU9603038A patent/HU227493B1/hu unknown
- 1995-05-02 RO RO96-02081A patent/RO113350B1/ro unknown
- 1995-05-02 WO PCT/FR1995/000565 patent/WO1995029929A1/fr active IP Right Grant
- 1995-05-02 ES ES95400987T patent/ES2122472T3/es not_active Expired - Lifetime
- 1995-05-02 HU HU9904687A patent/HU219599B/hu unknown
- 1995-05-02 GE GEAP19953425A patent/GEP19991538B/en unknown
- 1995-05-02 DE DE69505296T patent/DE69505296T2/de not_active Expired - Lifetime
- 1995-05-02 CN CN95193911A patent/CN1052984C/zh not_active Expired - Lifetime
- 1995-05-02 TN TNTNSN95049A patent/TNSN95049A1/fr unknown
- 1995-05-02 SK SK1402-96A patent/SK281707B6/sk not_active IP Right Cessation
- 1995-05-02 DZ DZ950049A patent/DZ1878A1/fr active
- 1995-05-02 RU RU96123129A patent/RU2144036C1/ru active
- 1995-05-02 AP APAP/P/1995/000744A patent/AP558A/en active
- 1995-05-02 EE EE9600151A patent/EE03263B1/xx active Protection Beyond IP Right Term
- 1995-05-02 BR BR9507700A patent/BR9507700A/pt not_active IP Right Cessation
- 1995-05-02 MD MD97-0010A patent/MD1233C2/ro unknown
- 1995-05-02 CZ CZ19963214A patent/CZ293455B6/cs not_active IP Right Cessation
- 1995-06-29 TW TW084106692A patent/TW341573B/zh not_active IP Right Cessation
-
1996
- 1996-10-31 FI FI964395A patent/FI111263B/fi not_active IP Right Cessation
- 1996-11-01 TJ TJ96000417A patent/TJ313B/xx unknown
- 1996-11-01 BG BG100951A patent/BG63087B1/bg unknown
- 1996-11-01 OA OA60917A patent/OA10319A/fr unknown
- 1996-11-01 LV LVP-96-421A patent/LV11739B/lv unknown
- 1996-11-04 NO NO964654A patent/NO308853B1/no not_active IP Right Cessation
-
1997
- 1997-01-09 US US08/780,861 patent/US6100404A/en not_active Expired - Lifetime
-
1998
- 1998-08-24 JP JP25181798A patent/JP3998828B2/ja not_active Expired - Lifetime
- 1998-11-05 HK HK98111758A patent/HK1010732A1/xx not_active IP Right Cessation
- 1998-12-07 CN CN98123072A patent/CN1088709C/zh not_active Expired - Lifetime
-
2001
- 2001-12-28 NO NO2001027C patent/NO2001027I1/no unknown
- 2001-12-28 NL NL300077C patent/NL300077I1/nl unknown
-
2002
- 2002-01-08 LU LU90872C patent/LU90872I2/xx unknown
-
2006
- 2006-11-21 JP JP2006314281A patent/JP4658902B2/ja not_active Expired - Lifetime
-
2007
- 2007-06-06 JP JP2007150991A patent/JP4750755B2/ja not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10820706B2 (en) | 2007-09-20 | 2020-11-03 | Herman Miller, Inc. | Load support structure |
CN105524132A (zh) * | 2014-09-30 | 2016-04-27 | 中国医学科学院药物研究所 | 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用 |
CN105524132B (zh) * | 2014-09-30 | 2019-07-02 | 中国医学科学院药物研究所 | 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用 |
CN107129514A (zh) * | 2016-03-02 | 2017-09-05 | 中国医学科学院药物研究所 | 红霉素a酮内酯类抗生素衍生物、其制备方法及应用 |
CN107129514B (zh) * | 2016-03-02 | 2019-12-13 | 中国医学科学院药物研究所 | 红霉素a酮内酯类抗生素衍生物、其制备方法及应用 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1052984C (zh) | 新的红霉素衍生物、其制备方法及其作为药物的应用 | |
CN1059445C (zh) | 红霉素的新型衍生物,其制备方法及作为药物的应用 | |
CN1098263C (zh) | 吡啶-2-基-甲胺衍生物、其制备方法及其作为药物的用途 | |
CN1043639C (zh) | 新的哌啶化合物、其制备方法和含有它们的药用组合物 | |
CN1269833C (zh) | 新的芳香酰胺、其制备方法以及作为药物的应用 | |
CN1639147A (zh) | 4,5-二氢-吡唑并[3,4-c]吡啶-2-酮类化合物的合成 | |
CN1240707C (zh) | 2-卤代-6-0-取代的酮内酯衍生物 | |
CN1238777A (zh) | 红霉素a衍生物 | |
CN1278266A (zh) | 6,11-桥连红霉素衍生物 | |
CN1950362A (zh) | 类胰蛋白酶抑制剂的制备方法 | |
CN1108657A (zh) | 雪花胺衍生物、其制备方法及其作为药物的用途 | |
CN1478096A (zh) | L-核酸衍生物及其合成方法 | |
CN1117491A (zh) | 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物 | |
CN1022569C (zh) | 制备泰乐菌素和10,11,12,13-四氢泰乐菌素衍生物的方法 | |
CN1040877C (zh) | 红霉素的新衍生物、它们的制备方法和作为药物的应用 | |
CN1305462A (zh) | 具有止喘、抗变态反应、抗炎、免疫调节和神经保护作用的新的1,5和3-o-取代1h-吲唑类化合物,其制备方法以及作为药物的应用 | |
CN1756753A (zh) | 苯并呋喃衍生物 | |
CN1798726A (zh) | 取代吲哚及一种制备取代吲哚的方法 | |
CN1237164A (zh) | 用作法呢基-蛋白转移酶抑制剂的化合物 | |
CN1956993A (zh) | 具有抗炎活性的大环内酯 | |
CN1307584A (zh) | 大环内酯lhrh拮抗剂 | |
CN1308342C (zh) | 核糖取代的芳族化合物,其制备方法和作为药物的应用 | |
CN1101916A (zh) | 17α和17β取代的酰基-3-羧基3,5-二烯甾族化合物 | |
CN88101987A (zh) | 喹啉羧酸衍生物和含有它们的抗菌剂 | |
CN1297556C (zh) | 苯并[b]色烯并-萘啶-7-酮和吡喃并[2',3':7,8]喹啉并[2,3-b]喹喔啉-7-酮化合物、其制备方法及药用组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: HOECHST MARION ROUSSEL INC. Free format text: FORMER NAME OR ADDRESS: ROUSSEL-UCLAF Owner name: VENTIS PHARMA S.A. Free format text: FORMER NAME OR ADDRESS: HOECHST MARION ROUSSEL INC. |
|
CP03 | Change of name, title or address |
Address after: French Anthony Patentee after: AVENTIS PHARMA S.A. Address before: French AUX Patentee before: Hoechst Marion Roussel Address after: French AUX Patentee after: HOECHST MARION ROUSSEL Address before: French Roman Patentee before: ROUSSEL UCLAF |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20150502 Granted publication date: 20000531 |